SAS has long been the gold standard in the clinical trial industry, being a pioneer in statistical analysis, data management, and reporting for decades. However, current trends show a large shift to more open source programming languages like R, causing discussions on whether the future will be open source or not. Whatever way this discussion might go, we know that open-source is here to stay, so how should we handle it?

During this webinar various Cytel expert programmers and application developers operating exclusively with open source programming languages like R, will discuss the impact of open source on drug development and help SAS programmers navigate this new paradigm.

Key topics

• Working in R
• Open-source mindset in a regulated world
• Application development